A research team at Taiwan's National Yang Ming Chiao Tung University (NYCU) has transferred the technology for its experimental stem cell therapy treatment for pulmonary fibrosis to two biotech companies, in a first step toward beginning clinical trials, it announced Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
MOFA bashes China over 'weaponized tourism' pressure on Palau
10/31/2024 11:39 PM - Society
Typhoon Kong-rey weakens, rain to intensify in western Taiwan: CWA
10/31/2024 10:56 PM - Society
Workplaces, schools to mostly reopen Friday across Taiwan
10/31/2024 10:22 PM - Business
Taiwan posts 3.97% year-on-year GDP growth in Q3
10/31/2024 09:52 PM - Society
Domestic flights to resume Friday except between Taipei and Matsu
10/31/2024 09:14 PM